Colorectal cancer is a significant global health concern, ranking as the third most common cancer worldwide. In 2022, there were approximately 1.9 million new cases and over 900,000 deaths attributed to this disease.Projections indicate a substantial increase in the global burden of colorectal cancer. By 2040, the number of new cases is expected to rise to 3.2 million annually, marking a 63% increase, and deaths are anticipated to reach 1.6 million per year, a 73% increase from 2022 figures.Notably, there is a concerning trend of rising incidence rates among younger adults. A study led by the American Cancer Society found that early-onset colorectal cancer rates are increasing in 27 out of 50 countries, with 14 countries, including the United States, experiencing rising rates in individuals under 50, while rates stabilize in older populations. These statistics underscore the importance of enhanced screening, early detection, and preventive measures to address the growing global impact of colorectal cancer.
FDA approves Bristol Meyers therapy june 2024 for colorectal therapy
IMU Price at posting:
3.9¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)